Free Trial

Calumet Specialty Products Partners (NASDAQ:CLMT) Trading Down 15.5% - What's Next?

Calumet Specialty Products Partners logo with Energy background
Remove Ads

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Get Free Report)'s share price traded down 15.5% during trading on Friday . The stock traded as low as $10.50 and last traded at $10.11. 73,969 shares traded hands during mid-day trading, a decline of 90% from the average session volume of 747,512 shares. The stock had previously closed at $11.96.

Analyst Upgrades and Downgrades

Several brokerages recently commented on CLMT. UBS Group raised shares of Calumet Specialty Products Partners from a "sell" rating to a "neutral" rating and dropped their price target for the stock from $15.00 to $12.00 in a research report on Monday, March 17th. TD Cowen lowered shares of Calumet Specialty Products Partners from a "buy" rating to a "hold" rating and dropped their price objective for the company from $26.00 to $16.00 in a research note on Tuesday, March 4th. Wells Fargo & Company cut their price target on Calumet Specialty Products Partners from $29.00 to $28.00 and set an "overweight" rating on the stock in a research note on Wednesday, March 5th. Finally, HC Wainwright reaffirmed a "buy" rating and issued a $33.00 price target on shares of Calumet Specialty Products Partners in a report on Monday, March 3rd. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the company. According to MarketBeat, Calumet Specialty Products Partners currently has a consensus rating of "Hold" and a consensus price target of $20.80.

Get Our Latest Stock Analysis on CLMT

Remove Ads

Calumet Specialty Products Partners Trading Up 0.8 %

The company has a market cap of $844.44 million, a price-to-earnings ratio of -3.56 and a beta of 1.42. The firm has a 50-day moving average price of $14.13 and a 200 day moving average price of $18.24.

Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last released its quarterly earnings data on Friday, February 28th. The oil and gas company reported ($0.47) EPS for the quarter, topping analysts' consensus estimates of ($1.06) by $0.59. The business had revenue of $949.50 million during the quarter, compared to analyst estimates of $921.76 million. The business's revenue for the quarter was down 2.8% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.59) EPS. Research analysts anticipate that Calumet Specialty Products Partners, L.P. will post -3.02 earnings per share for the current fiscal year.

Insider Activity

In other news, CFO David Lunin acquired 2,500 shares of the business's stock in a transaction that occurred on Tuesday, March 4th. The shares were purchased at an average cost of $13.05 per share, for a total transaction of $32,625.00. Following the transaction, the chief financial officer now directly owns 2,500 shares in the company, valued at $32,625. This trade represents a ∞ increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Stephen P. Mawer sold 3,655 shares of the stock in a transaction that occurred on Monday, March 24th. The stock was sold at an average price of $12.88, for a total value of $47,076.40. Following the completion of the transaction, the director now directly owns 287,307 shares of the company's stock, valued at $3,700,514.16. This trade represents a 1.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 2.91% of the company's stock.

Calumet Specialty Products Partners Company Profile

(Get Free Report)

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.

Read More

Should You Invest $1,000 in Calumet Specialty Products Partners Right Now?

Before you consider Calumet Specialty Products Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet Specialty Products Partners wasn't on the list.

While Calumet Specialty Products Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

5 Big Reasons the S&P 500 Could Soar in 2025
3 Stocks to Buy on the Dip—and 3 to Dump Fast
Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads